title: Reply to E. Grunfeld.
authors.affiliation: RTI International, Washington, DC and Research Triangle Park, NC; University of North Carolina-Chapel Hill, Chapel Hill, NC mhalpern@rti.org.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Halpern
authors.affiliation: RTI International, Washington, DC and Research Triangle Park, NC; University of North Carolina-Chapel Hill, Chapel Hill, NC.
authors.forename: Meera
authors.initials: M
authors.lastname: Viswanathan
authors.affiliation: RTI International, Washington, DC and Research Triangle Park, NC; University of North Carolina-Chapel Hill, Chapel Hill, NC.
authors.forename: Tammeka S
authors.initials: TS
authors.lastname: Evans
authors.affiliation: RTI International, Washington, DC and Research Triangle Park, NC; University of North Carolina-Chapel Hill, Chapel Hill, NC.
authors.forename: Sarah A
authors.initials: SA
authors.lastname: Birken
authors.affiliation: RTI International, Washington, DC and Research Triangle Park, NC; University of North Carolina-Chapel Hill, Chapel Hill, NC.
authors.forename: Ethan
authors.initials: E
authors.lastname: Basch
authors.affiliation: RTI International, Washington, DC and Research Triangle Park, NC; University of North Carolina-Chapel Hill, Chapel Hill, NC.
authors.forename: Deborah K
authors.initials: DK
authors.lastname: Mayer
mesh_terms: D006801:Humans; D008962:Models, Theoretical; D009369:Neoplasms / Q000628:therapy*; D017741:Survivors